Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells.

Günther C, Bello-Fernandez C, Kopp T, Kund J, Carballido-Perrig N, Hinteregger S, Fassl S, Schwärzler C, Lametschwandtner G, Stingl G, Biedermann T, Carballido JM.

J Immunol. 2005 Feb 1;174(3):1723-8.

2.

IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.

Kopp T, Lenz P, Bello-Fernandez C, Kastelein RA, Kupper TS, Stingl G.

J Immunol. 2003 Jun 1;170(11):5438-44.

3.

Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties.

Bello-Fernández C, Stasakova J, Renner A, Carballido-Perrig N, Koening M, Waclavicek M, Madjic O, Oehler L, Haas O, Carballido JM, Buschle M, Knapp W.

Blood. 2003 Mar 15;101(6):2184-90. Epub 2002 Nov 7.

4.

Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics.

Strobl H, Scheinecker C, Riedl E, Csmarits B, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W.

J Immunol. 1998 Jul 15;161(2):740-8.

5.

Epidermal Langerhans cell development and differentiation.

Strobl H, Riedl E, Bello-Fernandez C, Knapp W.

Immunobiology. 1998 Mar;198(5):588-605. Review.

PMID:
9561375
6.

Analysis of myeloid-associated genes in human hematopoietic progenitor cells.

Bello-Fernández C, Matyash M, Strobl H, Scheinecker C, Knapp W.

Exp Hematol. 1997 Oct;25(11):1158-66.

PMID:
9328452
7.

Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions.

Bello-Fernandez C, Matyash M, Strobl H, Pickl WF, Majdic O, Lyman SD, Knapp W.

Hum Gene Ther. 1997 Sep 20;8(14):1651-8.

PMID:
9322867
9.

Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation.

Parolini O, Berardelli S, Riedl E, Bello-Fernandez C, Strobl H, Majdic O, Knapp W.

Blood. 1997 Jul 1;90(1):70-5.

10.

TGF-beta 1 dependent generation of LAG+ dendritic cells from CD34+ progenitors in serum-free medium.

Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W.

Adv Exp Med Biol. 1997;417:161-5. No abstract available.

PMID:
9286354
11.

Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.

Pickl WF, Majdic O, Kohl P, Stöckl J, Riedl E, Scheinecker C, Bello-Fernandez C, Knapp W.

J Immunol. 1996 Nov 1;157(9):3850-9.

PMID:
8892615
12.

TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.

Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Rappersberger K, Majdic O, Knapp W.

J Immunol. 1996 Aug 15;157(4):1499-507.

PMID:
8759731
13.

Molecular characterization of CD34+ human hematopoietic progenitor cells.

Knapp W, Strobl H, Scheinecker C, Bello-Fernandez C, Majdic O.

Ann Hematol. 1995 Jun;70(6):281-96. Review. No abstract available.

PMID:
7543291
14.

Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse.

Richard C, Baro J, Bello-Fernandez C, Hermida G, Calavia J, Olalla I, Alsar MJ, Loyola I, Cuadrado MA, Iriondo A, et al.

Bone Marrow Transplant. 1995 May;15(5):721-6.

PMID:
7670401
15.

Position and orientation independent transactivation by c-Myc.

Packham G, Bello-Fernandez C, Cleveland JL.

Cell Mol Biol Res. 1994;40(7-8):699-706.

PMID:
7787888
16.

The ornithine decarboxylase gene is a transcriptional target of c-Myc.

Bello-Fernandez C, Packham G, Cleveland JL.

Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8.

17.

Recombinant human GM-CSF enhances T cell-mediated cytotoxic function after ABMT for hematological malignancies.

Richard C, Alsar MJ, Calavia J, Bello-Fernandez C, Baro J, Loyola I, Rios R, Cuadrado MA, Gonzalez-Pardo C, Iriondo A, et al.

Bone Marrow Transplant. 1993 Jun;11(6):473-8.

PMID:
8334429
18.
19.

c-myc transactivates the ornithine decarboxylase gene.

Bello-Fernandez C, Cleveland JL.

Curr Top Microbiol Immunol. 1992;182:445-52. No abstract available.

PMID:
1490383
20.

Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features.

Baro J, Richard C, Calavia J, González-San Miguel JD, Bello-Fernández C, Alsar MJ, Gómez-Casares MT, Iriondo A, Conde E, Hermosa V, et al.

Bone Marrow Transplant. 1991 Oct;8(4):283-9.

PMID:
1756325
21.

Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.

Oblakowski P, Bello-Fernandez C, Reittie JE, Heslop HE, Galatowicz G, Veys P, Wilkes S, Prentice HG, Hazlehurst G, Hoffbrand AV, et al.

Blood. 1991 May 1;77(9):1996-2001.

22.

Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function.

Bello-Fernandez C, Bird C, Heslop HE, Gottlieb DJ, Reittie JE, Rill DM, Holland M, Prentice HG, Brenner MK.

Blood. 1991 Mar 15;77(6):1283-9.

23.

Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation.

Heslop HE, Duncombe AS, Reittie JE, Bello-Fernandez C, Gottlieb DJ, Prentice HG, Mehta AB, Hoffbrand AV, Brenner MK.

Br J Haematol. 1991 Feb;77(2):237-44.

PMID:
2004026
24.

Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regeneration.

Heslop HE, Duncombe AS, Reittie JE, Bello-Fernandez C, Gottlieb DJ, Prentice HG, Hoffbrand AV, Brenner MK.

Transplant Proc. 1991 Feb;23(1 Pt 2):1704-5. No abstract available.

PMID:
1989334
25.

IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma.

Bello-Fernandez C, Oblakowski P, Meager A, Duncombe AS, Rill DM, Hoffbrand AV, Brenner MK.

Immunology. 1991 Feb;72(2):161-6. Erratum in: Immunology 1991 May;73(1):128.

26.

Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy.

Gottlieb DJ, Prentice HG, Heslop HE, Bello-Fernandez C, Bianchi AC, Galazka AR, Brenner MK.

Blood. 1989 Nov 15;74(7):2335-42.

27.

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease.

Gottlieb DJ, Brenner MK, Heslop HE, Bianchi AC, Bello-Fernandez C, Mehta AB, Newland AC, Galazka AR, Scott EM, Hoffbrand AV, et al.

Br J Cancer. 1989 Oct;60(4):610-5.

28.

Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy.

Heslop HE, Gottlieb DJ, Reittie JE, Bello-Fernandez C, Meager A, Prentice HG, Brenner MK.

Br J Haematol. 1989 Jun;72(2):122-6.

PMID:
2503022

Supplemental Content

Loading ...
Support Center